Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Figures in the National Profile

Data represented in many of the figures below can be downloaded at:  https://www.cdc.gov/std/stats17/figures/figureData.zip [ZIP – 529 KB]

Chlamydia

Figure 1. Chlamydia — Rates of Reported Cases by Sex, United States, 2000–2017

Figure 2. Chlamydia — Rates of Reported Cases by Region, United States, 2008–2017

Figure 3. Chlamydia — Rates of Reported Cases by State, United States and Outlying Areas, 2017

Figure 4. Chlamydia — Rates of Reported Cases by County, United States, 2017

Figure 5. Chlamydia — Rates of Reported Cases by Age Group and Sex, United States, 2017

Figure 6. Chlamydia — Rates of Reported Cases Among Women Aged 15–44 Years by Age Group, United States, 2008–2017

Figure 7. Chlamydia — Rates of Reported Cases Among Men Aged 15–44 Years by Age Group, United States, 2008–2017

Figure 8. Chlamydia — Rates of Reported Cases by Race and Hispanic Ethnicity, United States, 2013–2017

Figure 9. Chlamydia — Percentage of Reported Cases Among Men by Reporting Source, United States, 2008–2017

Figure 10. Chlamydia — Percentage of Reported Cases Among Women by Reporting Source, United States, 2008–2017

Figure 11. Chlamydia — National Estimates of Prevalence Among Persons Aged 14–39 Years by Sex, Race, Hispanic Ethnicity, or Age Group, National Health and Nutrition Examination Survey (NHANES), 2013–2016

Figure 12. Chlamydia — National Estimates of Prevalence Among Sexually-Active Women Aged 14–39 Years by Race, Hispanic Ethnicity, and Age Group, National Health and Nutrition Examination Survey (NHANES), 2013–2016

Figure 13. Chlamydia — Proportion of STD Clinic Patients Testing Positive by Age Group, Sex, and Sexual Behavior, STD Surveillance Network (SSuN), 2017

Gonorrhea

Figure 14. Gonorrhea — Rates of Reported Cases by Year, United States, 1941–2017

Figure 15. Gonorrhea — Rates of Reported Cases by Region, United States, 2008–2017

Figure 16. Gonorrhea — Rates of Reported Cases by State, United States and Outlying Areas, 2017

Figure 17. Gonorrhea — Rates of Reported Cases by County, United States, 2017

Figure 18. Gonorrhea — Rates of Reported Cases by Sex, United States, 2008–2017

Figure 19. Gonorrhea — Rates of Reported Cases by Age Group and Sex, United States, 2017

Figure 20. Gonorrhea — Rates of Reported Cases Among Women Aged 15–44 Years by Age Group, United States, 2008–2017

Figure 21. Gonorrhea — Rates of Reported Cases Among Men Aged 15–44 Years by Age Group, United States, 2008–2017

Figure 22. Gonorrhea — Rates of Reported Cases by Race and Hispanic Ethnicity, United States, 2013–2017

Figure 23. Gonorrhea — Percentage of Reported Cases Among Men by Reporting Source, United States, 2008–2017

Figure 24. Gonorrhea — Percentage of Reported Cases Among Women by Reporting Source, United States, 2008–2017

Figure 25.  Estimated Proportion of MSM, MSW, and Women Among Gonorrhea Cases by Jurisdiction, STD Surveillance Network (SSuN), 2017

Figure 26. Gonorrhea — Estimated Rates of Reported Gonorrhea Cases by MSM, MSW, and Women, STD Surveillance Network (SSuN), 2010–2017

Figure 27. Gonorrhea — Proportion of STD Clinic Patients Testing Positive by Age Group, Sex, and Sexual Behavior, STD Surveillance Network (SSuN), 2017

Figure 28. Location of Participating Sentinel Sites and Regional Laboratories, Gonococcal Isolate Surveillance Project (GISP), United States, 2017

Figure 29. Neisseria gonorrhoeae — Percentage of Isolates with Elevated Azithromycin Minimum Inhibitory Concentrations (MICs) (≥2.0 µg/ml), Elevated Ceftriaxone MICs (≥0.125 µg/ml), and Elevated Cefixime MICs (≥0.25 µg/ml), Gonococcal Isolate Surveillance Project (GISP), 2008–2017

Figure 30. Neisseria gonorrhoeae — Distribution of Gentamicin Minimum Inhibitory Concentrations (MICs) by Year, Gonococcal Isolate Surveillance Project (GISP), 2015–2017

Figure 31. Neisseria gonorrhoeae — Prevalence of Tetracycline, Penicillin, or Fluoroquinolone Resistance or Elevated Cefixime, Ceftriaxone, or Azithromycin Minimum Inhibitory Concentrations (MICs), by Year — Gonococcal Isolate Surveillance Project (GISP), 2000–2017

Figure 32. Susceptibility Patterns of Neisseria gonorrhoeae Isolates to Antimicrobials, Gonococcal Isolate Surveillance Project (GISP), 2017

Figure 33. Distribution of Primary Antimicrobial Drugs Used to Treat Gonorrhea Among Participants, Gonococcal Isolate Surveillance Project (GISP), 1988–2017

Figure 34. Gonorrhea — Estimated Proportion of Cases by Treatment Regimen Received and Jurisdiction, STD Surveillance Network (SSuN), 2017

Syphilis

Figure 35. Syphilis — Rates of Reported Cases by Stage of Infection, United States, 1941–2017

Figure 36. Primary and Secondary Syphilis — Rates of Reported Cases by Region, United States, 2008–2017

Figure 37. Primary and Secondary Syphilis — Rates of Reported Cases by State, United States and Outlying Areas, 2017

Figure 38. Primary and Secondary Syphilis — Rates of Reported Cases by County, United States, 2017

Figure 39. Primary and Secondary Syphilis — Distribution of Cases by Sex and Sexual Behavior, United States, 2017

Figure 40. Primary and Secondary Syphilis — Rates of Reported Cases by Sex and Male-to-Female Rate Ratios, United States, 1990–2017

Figure 41. Primary and Secondary Syphilis — Reported Cases by Sex and Sexual Behavior, 37 States, 2013–2017

Figure 42. Primary and Secondary Syphilis — Rates of Reported Cases by Age Group and Sex, United States, 2017

Figure 43. Primary and Secondary Syphilis — Rates of Reported Cases Among Women Aged 15–44 Years by Age Group, United States, 2008–2017

Figure 44. Primary and Secondary Syphilis — Rates of Reported Cases Among Men Aged 15–44 Years by Age Group, United States, 2008–2017

Figure 45. Primary and Secondary Syphilis — Rates of Reported Cases by Race and Hispanic Ethnicity, United States, 2013–2017

Figure 46. Primary and Secondary Syphilis — Reported Cases by Sex, Sexual Behavior, and HIV Status, United States, 2017

Figure 47. Primary and Secondary Syphilis — Reported Cases by Reporting Source and Sex, United States, 2008–2017

Figure 48. Primary and Secondary Syphilis — Percentage of Reported Cases by Sex, Sexual Behavior, and Selected Reporting Sources, United States, 2017

Figure 49. Congenital Syphilis — Reported Cases by Year of Birth and Rates of Reported Cases of Primary and Secondary Syphilis Among Women Aged 15–44 Years, United States, 2008–2017

Other STDs

Figure 50. Chancroid — Reported Cases by Year, United States, 1941–2017

Figure 51. Cervical Intraepithelial Neoplasia Grades 2 and 3 — Prevalence per 1000 Person-Years Among Female Enrollees in Private Health Plans Aged 15–39 Years, by Age Group and Year, 2007–2014

Figure 52. Anogenital Warts — Prevalence per 1000 Person-Years Among Enrollees in Private Health Plans Aged 15–39 Years by Sex, Age Group, and Year, 2006–2014

Figure 53. Herpes Simplex Virus Type 2 — National Estimates of Trends in Age-Adjusted Seroprevalence Among Persons Aged 14–49 Years by Race and Hispanic Ethnicity, National Health and Nutrition Examination Survey (NHANES), 1999–2000 through 2015–2016

Figure 54. Trichomonas vaginalis and Other Vaginal Infections Among Females — Initial Visits to Physicians’ Offices, United States, 1966–2016

TOP